Related Experiment Video
Updated: Jul 10, 2025
00:04
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.7K
Conduct and Implementation of Personalized Trials in Research and Practice
Richard L Kravitz1,2, Naihua Duan3,4
1Department of Internal Medicine, University of California, Davis.
Harvard Data Science Review
|November 27, 2023
Summary
Personalized trials, or N-of-1 trials, assess treatment effectiveness in individuals but face adoption barriers. Overcoming design and implementation challenges is key to their wider use in medicine.
Area of Science:
- Clinical Trials
- Medical Research Methodology
- Personalized Medicine
Background:
- Randomized controlled trials (RCTs) are standard for evidence development, focusing on average treatment effects.
- Personalized trials (N-of-1 trials) evaluate comparative treatment effectiveness within a single individual.
- Despite 40+ years of use, N-of-1 trials have seen limited adoption in medicine.
Purpose of the Study:
- To review the essential elements of personalized trials.
- To identify barriers to the widespread adoption of N-of-1 trials.
- To explore strategies for improving the deployability and utility of personalized trials.
Main Methods:
- Review of existing literature on personalized (N-of-1) trial design and implementation.
- Analysis of practical challenges including regimen flexibility, blinding, and washout periods.
- Discussion of organizational, clinician, and patient-level impediments.
Main Results:
- Limited evidence exists demonstrating improved outcomes with personalized trials.
- Practical design and implementation issues, not efficacy proof, are the primary barriers.
- Organizational and individual-level challenges hinder widespread adoption.
Conclusions:
- Personalized trials offer a valuable approach to assessing treatment effectiveness in individuals.
- Addressing practical design, implementation, and logistical challenges is crucial for broader adoption.
- Emerging technologies may overcome current barriers, enhancing future personalized trial research.
Keywords:
blindingheterogeneity of treatment effects (HTE)individualized treatment effect (ITE)personalized trialrandomized controlled trial (RCT)washoutMore Related Videos
06:16Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
Published on: June 6, 2020
3.8K
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.4K
Related Concept Videos
01:16Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
01:11Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
01:56Ethics in Research
23.0K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
23.0K
01:11Blinding
2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
130
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
130
02:07Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K